13 results on '"Marzouk, Evan"'
Search Results
2. Human immunodeficiency virus patients with low CD4 counts are more likely to have precancerous polyps identified during index colonoscopy
3. Romidepsin and lenalidomide‐based regimens have efficacy in relapsed/refractory lymphoma: Combined analysis of two phase I studies with expansion cohorts
4. Su1734 MAJORITY OF HOSPITALIZED PATIENTS LABELED AS HAVING GASTROPARESIS HAVE NEVER UNDERGONE DIAGNOSTIC EVALUATION
5. Mo1609 HIV PATIENTS WITH LOW CD4 COUNTS ARE MORE LIKELY TO DEVELOP PRE-CANCEROUS POLYPS
6. Mo1620 AGE, NOT GENDER, AFFECTS PATIENT COMPLIANCE WITH COLON CANCER SCREENING IN AN INNER-CITY URBAN POPULATION
7. The Combination of Duvelisib, a PI3K-δ,γ Inhibitor, and Romidepsin Is Highly Active in Relapsed/Refractory Peripheral T-Cell Lymphoma with Low Rates of Transaminitis: Results of Parallel Multicenter, Phase 1 Combination Studies with Expansion Cohorts
8. Short-term succinic acid treatment mitigates cerebellar mitochondrial OXPHOS dysfunction, neurodegeneration and ataxia in a Purkinje-specific spinocerebellar ataxia type 1 (SCA1) mouse model
9. In Vitro, In Vivo, and Parallel Phase I Evidence Support the Safety and Activity of Duvelisib, a PI3K-δ,γ Inhibitor, in Combination with Romidepsin or Bortezomib in Relapsed/Refractory T-Cell Lymphoma
10. Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
11. Canine Olfaction and Electronic Nose Detection of Volatile Organic Compounds in the Detection of Cancer: A Review
12. Transcutaneous pCO2 and Seizures in the Epilepsy Monitoring Unit: Associations with Markers of Seizure Severity (S14.003)
13. The Combination of Duvelisib, a PI3K-d,? Inhibitor, and Romidepsin Is Highly Active in Relapsed/Refractory Peripheral T-Cell Lymphoma with Low Rates of Transaminitis: Results of Parallel Multicenter, Phase 1 Combination Studies with Expansion Cohorts
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.